Страница 1+ · 50 сайта
| NCT00091442 | A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer | COMPLETED | PHASE3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Breast Cancer | — | Shumen | Шумен |
| NCT00097344 | The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | TERMINATED | PHASE3 | Intarcia Therapeutics | Breast Neoplasms; Neoplasms, Hormone-Dependent | Research Site | Shumen | Шумен |
| NCT00257608 | A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) | COMPLETED | PHASE3 | Genentech, Inc. | Non-Small Cell Lung Cancer | Regional Oncodispensary | Shumen | Шумен |
| NCT00274469 | A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer | COMPLETED | PHASE2 | AstraZeneca | Metastatic Breast Cancer | Research Site | Shumen | Шумен |
| NCT00337103 | E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes | COMPLETED | PHASE3 | Eisai Inc. | Metastatic Breast Cancer | — | Shumen | Шумен |
| NCT00366834 | Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting | COMPLETED | PHASE3 | GlaxoSmithKline | Vomiting; Nausea; Nausea and Vomiting, Chemotherapy-Induced | GSK Investigational Site | Shumen | Шумен |
| NCT00404352 | REbif FLEXible Dosing in Early Multiple Sclerosis (MS) | COMPLETED | PHASE3 | Merck KGaA, Darmstadt, Germany | Multiple Sclerosis | Research Site | Shumen | Шумен |
| NCT00465491 | Study of Picoplatin Efficacy After Relapse | UNKNOWN | PHASE3 | Poniard Pharmaceuticals | Small Cell Lung Cancer | Inter-district Dispensary for Cancer Diseases w/Inpatient Hospital | Shumen | Шумен |
| NCT00472303 | A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine | COMPLETED | PHASE3 | Grünenthal GmbH | Tumor; Pain | Site 359004 | Shumen | Шумен |
| NCT00490139 | ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D | COMPLETED | PHASE3 | Novartis Pharmaceuticals | Neoplasms, Breast | Novartis Investigative Site | Shumen | Шумен |
| NCT00601172 | A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. | COMPLETED | PHASE3 | GlaxoSmithKline | Nausea and Vomiting, Chemotherapy-Induced | GSK Investigational Site | Shumen | Шумен |
| NCT00605215 | BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) | COMPLETED | PHASE3 | Teva Branded Pharmaceutical Products R&D, Inc. | Multiple Sclerosis | Teva Investigational Site 5916 | Shumen | Шумен |
| NCT00641537 | CLARITY Extension Study | COMPLETED | PHASE3 | EMD Serono Research & Development Institute, Inc. | Relapsing-Remitting Multiple Sclerosis | Research Site | Shuman | Шумен |
| NCT00708552 | Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease | COMPLETED | PHASE2 | GlaxoSmithKline | Alzheimer's Disease | GSK Investigational Site | Shumen | Шумен |
| NCT00805194 | LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer | COMPLETED | PHASE3 | Boehringer Ingelheim | Carcinoma, Non-Small-Cell Lung | District Oncology Dispensary Shumen | Shumen | Шумен |
| NCT00813709 | Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) | COMPLETED | PHASE3 | Merck KGaA, Darmstadt, Germany | Multiple Sclerosis; Clinically Isolated Syndrome | Research Site | Shumen | Шумен |
| NCT00890305 | Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone | COMPLETED | PHASE2 | Medivation, Inc. | Metastatic Colorectal Cancer | InterDistrict Dispensary in Oncology Diseases with Stationary | Shumen | Шумен |
| NCT00989131 | Study of Paclitaxel in Patients With Ovarian Cancer | COMPLETED | PHASE3 | Oasmia Pharmaceutical AB | Epithelial Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer | Regional Oncology Dispensary | Shumen | Шумен |
| NCT01035255 | This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure | TERMINATED | PHASE3 | Novartis Pharmaceuticals | Heart Failure With Reduced Ejection Fraction | Novartis Investigative Site | Shumen | Шумен |
| NCT01047319 | A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis | TERMINATED | PHASE3 | Teva Branded Pharmaceutical Products R&D, Inc. | Relapsing Multiple Sclerosis | Teva Investigational Site 5916 | Shumen | Шумен |
| NCT01067521 | A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo | COMPLETED | PHASE3 | Teva Branded Pharmaceutical Products R&D, Inc. | Relapsing Remitting Multiple Sclerosis | Teva Investigational Site 5935 | Shumen | Шумен |
| NCT01075594 | Study of Undertreatment of Patients With Dyslipidemia in Bulgaria | COMPLETED | — | AstraZeneca | Dyslipidemia | Research Site | Shumen | Шумен |
| NCT01111552 | Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) | TERMINATED | PHASE3 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Major Depressive Disorder (MDD) | — | Tsarev Brod | Шумен |
| NCT01126190 | Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel | COMPLETED | PHASE3 | Teva Branded Pharmaceutical Products R&D, Inc. | Chemotherapy-induced Neutropenia | Teva Investigational Site 3501 | Shumen | Шумен |
| NCT01262651 | Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer | COMPLETED | PHASE3 | GW Pharmaceuticals Ltd | Pain; Advanced Cancer | — | Shumen | Шумен |
| NCT01264887 | Tapentadol in Chronic Malignant Tumour Related Pain | TERMINATED | PHASE3 | Grünenthal GmbH | Cancer; Chronic Pain; Pain | Site 359004 | Shumen | Шумен |
| NCT01376297 | A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting | COMPLETED | PHASE3 | Helsinn Healthcare SA | Chemotherapy-Induced Nausea and Vomiting | Complex Oncology Center - Shumen Ltd. [Oncology] | Shumen | Шумен |
| NCT01384292 | Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain | TERMINATED | PHASE3 | AstraZeneca | Opioid-Induced Constipation | Research Site | Shumen | Шумен |
| NCT01396447 | Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression | COMPLETED | PHASE2 | Forest Laboratories | Depression, Bipolar | Forest Investigative Site 308 | Tsarev Brod | Шумен |
| NCT01424566 | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | COMPLETED | PHASE3 | Jazz Pharmaceuticals | Pain; Advanced Cancer | — | Shumen | Шумен |
| NCT01431274 | Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | Boehringer Ingelheim | Pulmonary Disease, Chronic Obstructive | 1237.5.35906 Boehringer Ingelheim Investigational Site | Shumen | Шумен |
| NCT01543451 | Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea | COMPLETED | PHASE2 | Helsinn Healthcare SA | Diarrhea | Chemotherapy Department, Complex Oncology Center | Shumen | Шумен |
| NCT01578785 | An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) | TERMINATED | PHASE3 | Teva Branded Pharmaceutical Products R&D, Inc. | Relapsing-Remitting Multiple Sclerosis | Teva Investigational Site 59023 | Shumen | Шумен |
| NCT01619423 | A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE1, PHASE2 | Egetis Therapeutics | Advanced Metastatic (Stage IV) Colorectal Cancer | Complex Oncology Center-Shumen EOOD, Department of Medical Oncology | Shumen | Шумен |
| NCT01663727 | Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer | COMPLETED | PHASE3 | Hoffmann-La Roche | Metastatic Breast Cancer | Complex Oncological Center - Shumen, EOOD; Department of Chemotherapy | Shumen | Шумен |
| NCT01697072 | First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma | TERMINATED | PHASE3 | Amgen | Gastric Cancer | Research Site | Shumen | Шумен |
| NCT01705977 | Belimumab Assessment of Safety in SLE | COMPLETED | PHASE4 | GlaxoSmithKline | Systemic Lupus Erythematosus | GSK Investigational Site | Shumen | Шумен |
| NCT01707992 | The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) | COMPLETED | PHASE3 | Teva Branded Pharmaceutical Products R&D, Inc. | Multiple Sclerosis | Teva Investigational Site 59055 | Shumen | Шумен |
| NCT01715129 | Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer | COMPLETED | PHASE3 | Ipsen | Prostate Cancer | — | Shumen | Шумен |
| NCT01920711 | Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction | COMPLETED | PHASE3 | Novartis Pharmaceuticals | Heart Failure With Preserved Ejection Fraction | Novartis Investigative Site | Shumen | Шумен |
| NCT01923168 | Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women | COMPLETED | PHASE2 | Novartis Pharmaceuticals | Breast Cancer | Novartis Investigative Site | Shumen | Шумен |
| NCT01964378 | CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer | TERMINATED | PHASE3 | Tris Pharma, Inc. | Pain; Neoplasms; Chronic Pain | BG001 | Shumen | Шумен |
| NCT02031432 | CORAL XT - Open-label Extension Trial of the CORAL Trial | COMPLETED | PHASE3 | Tris Pharma, Inc. | Pain; Neoplasms; Chronic Pain | BG001 | Shumen | Шумен |
| NCT02137226 | BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE3 | Boehringer Ingelheim | Arthritis, Rheumatoid | MHAT Shumen AD, Shumen | Shumen | Шумен |
| NCT02174731 | Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis. | COMPLETED | PHASE3 | AstraZeneca | Anemia | Research Site | Shumen | Шумен |
| NCT02187055 | An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate | COMPLETED | PHASE4 | Pfizer | Rhematoid Arthritis | MHAT Shumen AD | Shumen | Шумен |
| NCT02226120 | Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction | COMPLETED | PHASE3 | Novartis Pharmaceuticals | Chronic Heart Failure With Reduced Ejection Fraction | Novartis Investigative Site | Shumen | Шумен |
| NCT02240238 | Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer | COMPLETED | PHASE1, PHASE2 | NanoCarrier Co., Ltd. | Solid Tumors | Complex Oncology Center - Shumen EOOD | Shumen | Шумен |
| NCT02278341 | Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis | COMPLETED | PHASE3 | Astellas Pharma Europe B.V. | Anemia; End Stage Renal Disease (ESRD) | Site BG35938 | Shumen | Шумен |
| NCT02364999 | A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC | COMPLETED | PHASE3 | Pfizer | Non-Small Cell Lung Cancer | Complex Oncological Center Shumen EOOD | Shumen | Шумен |
NCT00091442
A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer
COMPLETEDPHASE3Shumen · Шумен
Breast Cancer
Спонсор: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00097344
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
TERMINATEDPHASE3Shumen · Шумен
Breast Neoplasms; Neoplasms, Hormone-Dependent
Спонсор: Intarcia Therapeutics
Research Site
NCT00257608
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
COMPLETEDPHASE3Shumen · Шумен
Non-Small Cell Lung Cancer
Спонсор: Genentech, Inc.
Regional Oncodispensary
NCT00274469
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
COMPLETEDPHASE2Shumen · Шумен
Metastatic Breast Cancer
Спонсор: AstraZeneca
Research Site
NCT00337103
E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
COMPLETEDPHASE3Shumen · Шумен
Metastatic Breast Cancer
Спонсор: Eisai Inc.
NCT00366834
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
COMPLETEDPHASE3Shumen · Шумен
Vomiting; Nausea; Nausea and Vomiting, Chemotherapy-Induced
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT00404352
REbif FLEXible Dosing in Early Multiple Sclerosis (MS)
COMPLETEDPHASE3Shumen · Шумен
Multiple Sclerosis
Спонсор: Merck KGaA, Darmstadt, Germany
Research Site
NCT00465491
Study of Picoplatin Efficacy After Relapse
UNKNOWNPHASE3Shumen · Шумен
Small Cell Lung Cancer
Спонсор: Poniard Pharmaceuticals
Inter-district Dispensary for Cancer Diseases w/Inpatient Hospital
NCT00472303
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
COMPLETEDPHASE3Shumen · Шумен
Tumor; Pain
Спонсор: Grünenthal GmbH
Site 359004
NCT00490139
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
COMPLETEDPHASE3Shumen · Шумен
Neoplasms, Breast
Спонсор: Novartis Pharmaceuticals
Novartis Investigative Site
NCT00601172
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
COMPLETEDPHASE3Shumen · Шумен
Nausea and Vomiting, Chemotherapy-Induced
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT00605215
BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
COMPLETEDPHASE3Shumen · Шумен
Multiple Sclerosis
Спонсор: Teva Branded Pharmaceutical Products R&D, Inc.
Teva Investigational Site 5916
NCT00641537
CLARITY Extension Study
COMPLETEDPHASE3Shuman · Шумен
Relapsing-Remitting Multiple Sclerosis
Спонсор: EMD Serono Research & Development Institute, Inc.
Research Site
NCT00708552
Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
COMPLETEDPHASE2Shumen · Шумен
Alzheimer's Disease
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT00805194
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
COMPLETEDPHASE3Shumen · Шумен
Carcinoma, Non-Small-Cell Lung
Спонсор: Boehringer Ingelheim
District Oncology Dispensary Shumen
NCT00813709
Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)
COMPLETEDPHASE3Shumen · Шумен
Multiple Sclerosis; Clinically Isolated Syndrome
Спонсор: Merck KGaA, Darmstadt, Germany
Research Site
NCT00890305
Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone
COMPLETEDPHASE2Shumen · Шумен
Metastatic Colorectal Cancer
Спонсор: Medivation, Inc.
InterDistrict Dispensary in Oncology Diseases with Stationary
NCT00989131
Study of Paclitaxel in Patients With Ovarian Cancer
COMPLETEDPHASE3Shumen · Шумен
Epithelial Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
Спонсор: Oasmia Pharmaceutical AB
Regional Oncology Dispensary
NCT01035255
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
TERMINATEDPHASE3Shumen · Шумен
Heart Failure With Reduced Ejection Fraction
Спонсор: Novartis Pharmaceuticals
Novartis Investigative Site
NCT01047319
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
TERMINATEDPHASE3Shumen · Шумен
Relapsing Multiple Sclerosis
Спонсор: Teva Branded Pharmaceutical Products R&D, Inc.
Teva Investigational Site 5916
NCT01067521
A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo
COMPLETEDPHASE3Shumen · Шумен
Relapsing Remitting Multiple Sclerosis
Спонсор: Teva Branded Pharmaceutical Products R&D, Inc.
Teva Investigational Site 5935
NCT01075594
Study of Undertreatment of Patients With Dyslipidemia in Bulgaria
COMPLETEDShumen · Шумен
Dyslipidemia
Спонсор: AstraZeneca
Research Site
NCT01111552
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
TERMINATEDPHASE3Tsarev Brod · Шумен
Major Depressive Disorder (MDD)
Спонсор: Otsuka Pharmaceutical Development & Commercialization, Inc.
NCT01126190
Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel
COMPLETEDPHASE3Shumen · Шумен
Chemotherapy-induced Neutropenia
Спонсор: Teva Branded Pharmaceutical Products R&D, Inc.
Teva Investigational Site 3501
NCT01262651
Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
COMPLETEDPHASE3Shumen · Шумен
Pain; Advanced Cancer
Спонсор: GW Pharmaceuticals Ltd
NCT01264887
Tapentadol in Chronic Malignant Tumour Related Pain
TERMINATEDPHASE3Shumen · Шумен
Cancer; Chronic Pain; Pain
Спонсор: Grünenthal GmbH
Site 359004
NCT01376297
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
COMPLETEDPHASE3Shumen · Шумен
Chemotherapy-Induced Nausea and Vomiting
Спонсор: Helsinn Healthcare SA
Complex Oncology Center - Shumen Ltd. [Oncology]
NCT01384292
Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain
TERMINATEDPHASE3Shumen · Шумен
Opioid-Induced Constipation
Спонсор: AstraZeneca
Research Site
NCT01396447
Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
COMPLETEDPHASE2Tsarev Brod · Шумен
Depression, Bipolar
Спонсор: Forest Laboratories
Forest Investigative Site 308
NCT01424566
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
COMPLETEDPHASE3Shumen · Шумен
Pain; Advanced Cancer
Спонсор: Jazz Pharmaceuticals
NCT01431274
Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
COMPLETEDPHASE3Shumen · Шумен
Pulmonary Disease, Chronic Obstructive
Спонсор: Boehringer Ingelheim
1237.5.35906 Boehringer Ingelheim Investigational Site
NCT01543451
Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea
COMPLETEDPHASE2Shumen · Шумен
Diarrhea
Спонсор: Helsinn Healthcare SA
Chemotherapy Department, Complex Oncology Center
NCT01578785
An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)
TERMINATEDPHASE3Shumen · Шумен
Relapsing-Remitting Multiple Sclerosis
Спонсор: Teva Branded Pharmaceutical Products R&D, Inc.
Teva Investigational Site 59023
NCT01619423
A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer
COMPLETEDPHASE1, PHASE2Shumen · Шумен
Advanced Metastatic (Stage IV) Colorectal Cancer
Спонсор: Egetis Therapeutics
Complex Oncology Center-Shumen EOOD, Department of Medical Oncology
NCT01663727
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
COMPLETEDPHASE3Shumen · Шумен
Metastatic Breast Cancer
Спонсор: Hoffmann-La Roche
Complex Oncological Center - Shumen, EOOD; Department of Chemotherapy
NCT01697072
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
TERMINATEDPHASE3Shumen · Шумен
Gastric Cancer
Спонсор: Amgen
Research Site
NCT01705977
Belimumab Assessment of Safety in SLE
COMPLETEDPHASE4Shumen · Шумен
Systemic Lupus Erythematosus
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT01707992
The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
COMPLETEDPHASE3Shumen · Шумен
Multiple Sclerosis
Спонсор: Teva Branded Pharmaceutical Products R&D, Inc.
Teva Investigational Site 59055
NCT01715129
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer
COMPLETEDPHASE3Shumen · Шумен
Prostate Cancer
Спонсор: Ipsen
NCT01920711
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
COMPLETEDPHASE3Shumen · Шумен
Heart Failure With Preserved Ejection Fraction
Спонсор: Novartis Pharmaceuticals
Novartis Investigative Site
NCT01923168
Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women
COMPLETEDPHASE2Shumen · Шумен
Breast Cancer
Спонсор: Novartis Pharmaceuticals
Novartis Investigative Site
NCT01964378
CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer
TERMINATEDPHASE3Shumen · Шумен
Pain; Neoplasms; Chronic Pain
Спонсор: Tris Pharma, Inc.
BG001
NCT02031432
CORAL XT - Open-label Extension Trial of the CORAL Trial
COMPLETEDPHASE3Shumen · Шумен
Pain; Neoplasms; Chronic Pain
Спонсор: Tris Pharma, Inc.
BG001
NCT02137226
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
COMPLETEDPHASE3Shumen · Шумен
Arthritis, Rheumatoid
Спонсор: Boehringer Ingelheim
MHAT Shumen AD, Shumen
NCT02174731
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.
COMPLETEDPHASE3Shumen · Шумен
Anemia
Спонсор: AstraZeneca
Research Site
NCT02187055
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
COMPLETEDPHASE4Shumen · Шумен
Rhematoid Arthritis
Спонсор: Pfizer
MHAT Shumen AD
NCT02226120
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
COMPLETEDPHASE3Shumen · Шумен
Chronic Heart Failure With Reduced Ejection Fraction
Спонсор: Novartis Pharmaceuticals
Novartis Investigative Site
NCT02240238
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
COMPLETEDPHASE1, PHASE2Shumen · Шумен
Solid Tumors
Спонсор: NanoCarrier Co., Ltd.
Complex Oncology Center - Shumen EOOD
NCT02278341
Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
COMPLETEDPHASE3Shumen · Шумен
Anemia; End Stage Renal Disease (ESRD)
Спонсор: Astellas Pharma Europe B.V.
Site BG35938
NCT02364999
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
COMPLETEDPHASE3Shumen · Шумен
Non-Small Cell Lung Cancer
Спонсор: Pfizer
Complex Oncological Center Shumen EOOD
Страница 1+